BIIB in the 13F filings
Biogen Inc · CUSIP 09062X103
- Quarter end
- 31 Mar 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 12 May 2026
- Managers listing it
- 30
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q4 2025 and Q1 2026; 18 listed it in both
- Shares listed
- 24,577,083
- combined, among listed positions
- Reported value
- $4.5bn
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 13 buyers (opened or added shares) and 22 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -1,398,722.
Managers listing BIIB in Q1 2026
30 of 30 holders
Largest increases and reductions, by shares
Increases
- Fidelity (FMR LLC)existing position · 12,807,541 shares now+3,381,678
- AQR Capital Management LLCexisting position · 1,923,557 shares now+394,941
- ExodusPoint Capital Management LPnew position · 151,993 shares now+151,993
- Citadel Advisors LLCexisting position · 138,093 shares now+97,669
- Invesco Ltdexisting position · 1,745,255 shares now+89,814
Reductions
- Point72 Asset Management LPexisting position · 809,617 shares now-2,003,575
- Millennium Management LLCexisting position · 93,964 shares now-1,031,622
- Wellington Management Group LLPexisting position · 2,961,641 shares now-589,628
- Susquehanna International Group LLPexisting position · 140,299 shares now-521,385
- Two Sigma Investments LPexisting position · 9,444 shares now-242,319
New positions and exits
New (2)
Exited (6)
- Freestone Grove Partners LPwas $33m
- Brevan Howard Capital Management LPwas $12m
- D. E. Shaw & Co.was $9.5m
- Arrowstreet Capital LPwas $8.0m
- Verition Fund Management LLCwas $3.3m
- Quantbot Technologies LPwas $0
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 23 | $12.7bn | n.a. | n.a. |
| Q3 2013 | 20 | $14.3bn | n.a. | n.a. |
| Q4 2013 | 20 | $16.1bn | n.a. | n.a. |
| Q1 2014 | 21 | $16.8bn | n.a. | n.a. |
| Q2 2014 | 18 | $16.8bn | n.a. | n.a. |
| Q3 2014 | 23 | $16.4bn | n.a. | n.a. |
| Q4 2014 | 22 | $15.7bn | n.a. | n.a. |
| Q1 2015 | 24 | $20.3bn | n.a. | n.a. |
| Q2 2015 | 24 | $20.5bn | n.a. | n.a. |
| Q3 2015 | 24 | $12.4bn | n.a. | n.a. |
| Q4 2015 | 27 | $11.9bn | n.a. | n.a. |
| Q1 2016 | 27 | $10.3bn | n.a. | n.a. |
| Q2 2016 | 24 | $9.5bn | n.a. | n.a. |
| Q3 2016 | 29 | $11.6bn | n.a. | n.a. |
| Q4 2016 | 31 | $10.9bn | n.a. | n.a. |
| Q1 2017 | 25 | $9.2bn | n.a. | n.a. |
| Q2 2017 | 28 | $9.8bn | n.a. | n.a. |
| Q3 2017 | 24 | $11.6bn | n.a. | n.a. |
| Q4 2017 | 22 | $11.8bn | n.a. | n.a. |
| Q1 2018 | 28 | $9.6bn | n.a. | n.a. |
| Q2 2018 | 25 | $8.9bn | n.a. | n.a. |
| Q3 2018 | 28 | $10.6bn | n.a. | n.a. |
| Q4 2018 | 28 | $9.0bn | n.a. | n.a. |
| Q1 2019 | 22 | $7.4bn | n.a. | n.a. |
| Q2 2019 | 28 | $7.2bn | n.a. | n.a. |
| Q3 2019 | 28 | $7.1bn | n.a. | n.a. |
| Q4 2019 | 27 | $7.7bn | n.a. | n.a. |
| Q1 2020 | 25 | $7.3bn | n.a. | n.a. |
| Q2 2020 | 29 | $5.1bn | n.a. | n.a. |
| Q3 2020 | 25 | $5.1bn | n.a. | n.a. |
| Q4 2020 | 22 | $4.6bn | n.a. | n.a. |
| Q1 2021 | 18 | $4.7bn | n.a. | n.a. |
| Q2 2021 | 25 | $5.4bn | n.a. | n.a. |
| Q3 2021 | 23 | $3.3bn | n.a. | n.a. |
| Q4 2021 | 25 | $3.7bn | n.a. | n.a. |
| Q1 2022 | 29 | $3.7bn | n.a. | n.a. |
| Q2 2022 | 25 | $3.4bn | n.a. | n.a. |
| Q3 2022 | 33 | $5.2bn | n.a. | n.a. |
| Q4 2022 | 28 | $5.0bn | n.a. | n.a. |
| Q1 2023 | 30 | $5.1bn | n.a. | n.a. |
| Q2 2023 | 23 | $4.4bn | n.a. | n.a. |
| Q3 2023 | 21 | $2.9bn | n.a. | n.a. |
| Q4 2023 | 17 | $2.8bn | 11 | 8 |
| Q1 2024 | 16 | $2.5bn | 9 | 10 |
| Q2 2024 | 14 | $2.5bn | 6 | 8 |
| Q3 2024 | 17 | $2.6bn | 15 | 2 |
| Q4 2024 | 20 | $2.6bn | 16 | 4 |
| Q1 2025 | 22 | $2.4bn | 15 | 10 |
| Q2 2025 | 20 | $2.5bn | 15 | 5 |
| Q3 2025 | 21 | $2.8bn | 13 | 8 |
| Q4 2025 | 20 | $3.9bn | 12 | 25 |
| Q1 2026 | 16 | $3.9bn | 13 | 22 |
| Q2 2026 | 12 | $5.8bn | 16 | 17 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
BIIB and GILD →BIIB and AMGN →BIIB and ARGX →Choose a stock to compare with BIIB →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own BIIB, latest filings →Back to the 13F Explorer →